High Grade Ovarian Serous Adenocarcinoma
Also known as: High-grade Ovarian Serous Adenocarcinoma / Ovarian High Grade Serous Adenocarcinoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11740 | Adavosertib | 0 | Active Not Recruiting | 1 |
DB09074 | Olaparib | 0 | Active Not Recruiting | 1 |
DB11760 | Talazoparib | 0 | Completed | 1 |
DB00062 | Albumin human | 1 | Active Not Recruiting | 1 |
DB17450 | Albumin-stabilized nanoparticle (130 nm) | 1 | Active Not Recruiting | 1 |
DB11105 | Benzalkonium | 1 | Recruiting | 1 |
DB11794 | Berzosertib | 1 | Active Not Recruiting | 1 |
DB00112 | Bevacizumab | 1 | Active Not Recruiting | 1 |
DB00958 | Carboplatin | 1 | Active Not Recruiting | 1 |
DB00958 | Carboplatin | 1 | Recruiting | 1 |
DB12483 | Copanlisib | 1 | Active Not Recruiting | 1 |
DB00997 | Doxorubicin | 1 | Recruiting | 1 |
DB11841 | Entinostat | 1 | Terminated | 1 |
DB00441 | Gemcitabine | 1 | Active Not Recruiting | 2 |
DB11743 | Ipatasertib | 1 | Recruiting | 1 |
DB16252 | Nedisertib | 1 | Recruiting | 1 |
DB11793 | Niraparib | 1 | Active Not Recruiting | 1 |
DB09074 | Olaparib | 1 | Terminated | 1 |
DB01229 | Paclitaxel | 1 | Active Not Recruiting | 1 |
DB01229 | Paclitaxel | 1 | Recruiting | 1 |
DB00759 | Tetracycline | 1 | Recruiting | 1 |
DB11782 | Birinapant | 1 / 2 | Withdrawn | 1 |
DB12218 | Capivasertib | 1 / 2 | Active Not Recruiting | 1 |
DB00958 | Carboplatin | 1 / 2 | Active Not Recruiting | 1 |
DB00958 | Carboplatin | 1 / 2 | Withdrawn | 1 |
DB04849 | Cediranib | 1 / 2 | Active Not Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 / 2 | Active Not Recruiting | 1 |
DB01073 | Fludarabine | 1 / 2 | Active Not Recruiting | 1 |
DB17367 | Gavocabtagene autoleucel | 1 / 2 | Active Not Recruiting | 1 |
DB06186 | Ipilimumab | 1 / 2 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 1 / 2 | Active Not Recruiting | 1 |
DB09074 | Olaparib | 1 / 2 | Active Not Recruiting | 2 |
DB01229 | Paclitaxel | 1 / 2 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 1 |
DB08877 | Ruxolitinib | 1 / 2 | Active Not Recruiting | 1 |
DB11925 | Vistusertib | 1 / 2 | Active Not Recruiting | 1 |
DB14809 | Anetumab ravtansine | 2 | Active Not Recruiting | 1 |
DB01117 | Atovaquone | 2 | Recruiting | 1 |
DB00112 | Bevacizumab | 2 | Active Not Recruiting | 1 |
DB04849 | Cediranib | 2 | Active Not Recruiting | 1 |
DB09078 | Lenvatinib | 2 | Recruiting | 1 |
DB11793 | Niraparib | 2 | Recruiting | 1 |
DB09074 | Olaparib | 2 | Active Not Recruiting | 2 |
DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
DB11771 | Tremelimumab | 2 | Active Not Recruiting | 1 |
DB11595 | Atezolizumab | 2 / 3 | Active Not Recruiting | 1 |
DB00112 | Bevacizumab | 2 / 3 | Active Not Recruiting | 1 |
DB00997 | Doxorubicin | 2 / 3 | Active Not Recruiting | 1 |
DB00759 | Tetracycline | 2 / 3 | Active Not Recruiting | 1 |